Key players in the global cytology and HPV Testing market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global cytology and HPV Testing market. A few expansion strategies adopted by players operating in the global cytology and HPV Testing market are:
The report on the global cytology and HPV Testing market discussed individual strategies, followed by company profiles of manufacturers of cytology and HPV Testing. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cytology and HPV Testing market.
Cytology and HPV testing market to reach US$ 12.54 Bn by 2027
Cytology and HPV testing market is anticipated to expand at a CAGR of 5.9% from 2019 to 2027
Cytology and HPV testing market is driven by increasing incidence of HPV infections and cervical cancer and weakening immune system of the population
North America accounted for a major share of the global cytology and HPV testing market
Key players in the global cytology and HPV testing market Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cytology and HPV Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cytology and HPV Testing Market Analysis and Forecasts, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
6. Global Cytology and HPV Testing Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast by Product, 2017–2027
6.3.1. HPV Testing
6.3.1.1. Assay Kits
6.3.1.2. Systems
6.3.1.3. Services
6.3.2. Cytology Testing
6.3.2.1. Assay Kits
6.3.2.2. Systems
6.3.2.3. Services
6.4. Market Attractiveness by Product
7. Global Cytology and HPV Testing Market Analysis and Forecasts, by Region
7.1. Key Findings
7.2. Market Value Forecast by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness by Country/Region
8. North America Cytology and HPV Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast by Product, 2017–2027
8.2.1. HPV Testing
8.2.1.1. Assay Kits
8.2.1.2. Systems
8.2.1.3. Services
8.2.2. Cytology Testing
8.2.2.1. Assay Kits
8.2.2.2. Systems
8.2.2.3. Services
8.3. Market Value Forecast by Country, 2017–2027
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product Type
8.4.2. By Country
9. Europe Cytology and HPV Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast by Product, 2017–2027
9.2.1. HPV Testing
9.2.1.1. Assay Kits
9.2.1.2. Systems
9.2.1.3. Services
9.2.2. Cytology Testing
9.2.2.1. Assay Kits
9.2.2.2. Systems
9.2.2.3. Services
9.3. Market Value Forecast by Country/Sub-region, 2017–2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product Type
9.4.2. By Country/Sub-region
10. Asia Pacific Cytology and HPV Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast by Product, 2017–2027
10.2.1. HPV Testing
10.2.1.1. Assay Kits
10.2.1.2. Systems
10.2.1.3. Services
10.2.2. Cytology Testing
10.2.2.1. Assay Kits
10.2.2.2. Systems
10.2.2.3. Services
10.3. Market Value Forecast by Country/Sub-region, 2017–2027
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By Country/Sub-region
11. Latin America Cytology and HPV Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast by Product, 2017–2027
11.2.1. HPV Testing
11.2.1.1. Assay Kits
11.2.1.2. Systems
11.2.1.3. Services
11.2.2. Cytology Testing
11.2.2.1. Assay Kits
11.2.2.2. Systems
11.2.2.3. Services
11.3. Market Value Forecast by Country/Sub-region, 2017–2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Product Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Cytology and HPV Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast by Product, 2017–2027
12.2.1. HPV Testing
12.2.1.1. Assay Kits
12.2.1.2. Systems
12.2.1.3. Services
12.2.2. Cytology Testing
12.2.2.1. Assay Kits
12.2.2.2. Systems
12.2.2.3. Services
12.3. Market Value Forecast by Country/Sub-region, 2017–2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Product
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (by Tier and Size of companies)
13.2. Market Share Analysis by Company (2018)
13.3. Company Profiles
13.3.1. Becton, Dickinson and Company
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Growth Strategies
13.3.1.3. SWOT Analysis
13.3.2. Cepheid, Inc.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Growth Strategies
13.3.2.3. SWOT Analysis
13.3.3. Abbott Laboratories, Inc.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Growth Strategies
13.3.3.3. SWOT Analysis
13.3.4. F. Hoffmann-La Roche AG
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Growth Strategies
13.3.4.3. SWOT Analysis
13.3.5. Fujirebio Diagnostics, Inc.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Growth Strategies
13.3.5.3. SWOT Analysis
13.3.6. Arbor Vita Corporation
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Growth Strategies
13.3.6.3. SWOT Analysis
13.3.7. Hologic, Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Growth Strategies
13.3.7.3. SWOT Analysis
13.3.8. QIAGEN N.V.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Growth Strategies
13.3.8.3. SWOT Analysis
13.3.9. OncoHealth Corporation
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Growth Strategies
13.3.9.3. SWOT Analysis
List of Tables
TABLE 01: Global Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 02: Global Cytology and HPV Testing Market Size (US$ Mn) Forecast, By HPV Testing Type, 2017–2027
TABLE 03: Global Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Cytology Testing Type, 2017–2027
TABLE 04: Global Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Region, 2017–2027
TABLE 05: North America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 06: North America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By HPV Testing, 2017–2027
TABLE 07: North America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Cytology Testing, 2017–2027
TABLE 08: North America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Country, 2017–2027
TABLE 09: Europe Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 10: Europe Cytology and HPV Testing Market Size (US$ Mn) Forecast, By HPV Testing, 2017–2027
TABLE 11: Europe Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Cytology Testing, 2017–2027
TABLE 12: Europe Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Country, 2017–2027
TABLE 13: Latin America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 14: Latin America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By HPV Testing Type, 2017–2027
TABLE 15: Latin America Cytology and HPV Testing Market Size (US$ Mn) Forecast By Cytology Testing, 2017–2027
TABLE 16: Latin America Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Country, 2017–2027
TABLE 17: APAC Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 18: APAC Cytology and HPV Testing Markets Size (US$ Mn) Forecast, by HPV Testing, 2017–2027
TABLE 19: APAC Cytology and HPV Testing Market Size (US$ Mn) Forecast, by Cytology Testing, 2017–2027
TABLE 20: APAC Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Country, 2017–2027
TABLE 21: MEA Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Product, 2017–2027
TABLE 22: MEA Cytology and HPV Testing Market Size (US$ Mn) Forecast, By HPV Testing, 2017–2027
TABLE 23: MEA Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Cytology Testing, 2017–2027
TABLE 24: MEA Cytology and HPV Testing Market Size (US$ Mn) Forecast, By Country, 2017–2027
List of Figures
FIGURE 1 Global Cytology and HPV Testing Market Value Share Analysis, 2019 and 2027
FIGURE 2 Global Cytology and HPV Testing Market Value Share Analysis By Product, 2019 and 2027
FIGURE 3 Global Cytology and HPV Testing Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 4 Global Cytology and HPV Testing Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 5 Global Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 6 Global Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By HPV Testing, 2018–2027
FIGURE 7 Global Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Cytology Testing, 2018–2027
FIGURE 8 Global Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Region, 2018–2027
FIGURE 9 Global Cytology and HPV Testing Market Attractiveness Analysis, by Product
FIGURE 10 Global Cytology and HPV Testing Market Value Share Analysis By Region, 2019 and 2027
FIGURE 11 Global Cytology and HPV Testing Market Attractiveness Analysis, by Region
FIGURE 12 North America Cytology and HPV Testing Market Size (US$ Mn) Forecast, 2017–2027
FIGURE 13 North America Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 14 North America Cytology and HPV Testing Market Attractiveness Analysis, by Country
FIGURE 15 North America Market Value Share Analysis By Product, 2019 and 2027
FIGURE 16 North America Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 17 North America Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 18 North America Market Value Share Analysis By Country, 2019 and 2027
FIGURE 19 North America Market Attractiveness Analysis, by Product
FIGURE 20 Europe Cytology and HPV Testing Market Size (US$ Mn) Forecast, 2017–2027
FIGURE 21 Europe Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 22 Europe Cytology and HPV Testing Market Attractiveness Analysis, by Country
FIGURE 23 Europe Market Value Share Analysis By Product, 2019 and 2027
FIGURE 24 Europe Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 25 Europe Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 26 Europe Market Value Share Analysis By Country, 2019 and 2027
FIGURE 27 Europe Market Attractiveness Analysis, by Product
FIGURE 28 Latin America Cytology and HPV Testing Market Size (US$ Mn) Forecast, 2017–2027
FIGURE 29 Latin America Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 30 Latin America Cytology and HPV Testing Market Attractiveness Analysis, by Country
FIGURE 31 Latin America Market Value Share Analysis By Product, 2019 and 2027
FIGURE 32 Latin America Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 33 Latin America Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 34 Latin America Market Value Share Analysis By Country, 2019 and 2027
FIGURE 35 Latin America Market Attractiveness Analysis, by Product
FIGURE 36 APAC Cytology and HPV Testing Market Size (US$ Mn) Forecast, 2017–2027
FIGURE 37 APAC Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 38 APAC Cytology and HPV Testing Market Attractiveness Analysis, by Country
FIGURE 39 APAC Market Value Share Analysis By Product, 2019 and 2027
FIGURE 40 APAC Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 41 APAC Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 42 APAC Market Value Share Analysis By Country, 2019 and 2027
FIGURE 43 APAC Market Attractiveness Analysis, by Product
FIGURE 44 MEA Cytology and HPV Testing Market Size (US$ Mn) Forecast, 2017–2027
FIGURE 45 MEA Cytology and HPV Testing Market Revenue (US$ Mn) and Y-o-Y growth (%), By Product, 2018–2027
FIGURE 46 MEA Cytology and HPV Testing Market Attractiveness Analysis, by Country
FIGURE 47 MEA Market Value Share Analysis By Product, 2019 and 2027
FIGURE 48 MEA Market Value Share Analysis By HPV Testing, 2019 and 2027
FIGURE 49 MEA Market Value Share Analysis By Cytology Testing, 2019 and 2027
FIGURE 50 MEA Market Value Share Analysis By Country, 2019 and 2027
FIGURE 51 MEA Market Attractiveness Analysis, by Product
FIGURE 52 Global Cytology and HPV Testing Market Share Analysis By Company (2018)
FIGURE 53 Becton, Dickinson and Company Breakdown of Net Sales, by Region, 2018
FIGURE 54 Becton, Dickinson and Company Breakdown of Net Sales, by Segment, 2018
FIGURE 55 Becton, Dickinson and Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 56 Cepheid, Inc. Breakdown of Net Sales, by Region, 2018
FIGURE 57 Cepheid, Inc. Breakdown of Net Sales, by Segment, 2018
FIGURE 58 Cepheid, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 59 Abbott Laboratories, Inc. Breakdown of Net Sales, by Region, 2018
FIGURE 60 Abbott Laboratories, Inc. Breakdown of Net Sales, by Segment, 2018
FIGURE 61 Abbott Laboratories, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 62 F. Hoffmann-La Roche AG Breakdown of Net Sales, by Region, 2018
FIGURE 63 F. Hoffmann-La Roche AG Breakdown of Net Sales, by Segment, 2018
FIGURE 64 F. Hoffmann-La Roche AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 65 Fujirebio Diagnostics, Inc. Breakdown of Net Sales, by Region, 2018
FIGURE 66 Fujirebio Diagnostics, Inc. Breakdown of Net Sales, by Segment, 2018
FIGURE 67 Fujirebio Diagnostics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 68 Arbor Vita Corporation Breakdown of Net Sales, by Region, 2018
FIGURE 69 Arbor Vita Corporation Breakdown of Net Sales, by Segment, 2018
FIGURE 70 Arbor Vita Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 71 Hologic, Inc. Breakdown of Net Sales, by Region, 2018
FIGURE 72 Hologic, Inc. Breakdown of Net Sales, by Segment, 2018
FIGURE 73 Hologic, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 74 QIAGEN N.V. Breakdown of Net Sales, by Region, 2018
FIGURE 75 QIAGEN N.V. Breakdown of Net Sales, by Segment, 2018
FIGURE 76 QIAGEN N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
FIGURE 77 OncoHealth Corporation Breakdown of Net Sales, by Region, 2018
FIGURE 78 OncoHealth Corporation Breakdown of Net Sales, by Segment, 2018
FIGURE 79 OncoHealth Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cytology and HPV Testing Market
